Your browser doesn't support javascript.
loading
Setting up pharmacovigilance based on available endTB Project data for bedaquiline.
Lachenal, N; Hewison, C; Mitnick, C; Lomtadze, N; Coutisson, S; Osso, E; Ahmed, S; Leblanc, G; Islam, S; Atshemyan, H; Nair, P; Kholikulov, B; Aiylchiev, S; Zarli, K; Adnan, S; Krisnanda, A; Padayachee, S; Stambekova, A; Sahabutdinova, Y; de Guadalupe, S; Moreno, Perea; Kumsa, A; Reshid, A; Makaka, J; Abebe, S; Melikyan, N; Seung, K J; Khan, U; Khan, P; Huerga, H; Rich, M; Varaine, F.
Afiliação
  • Lachenal N; Médecins Sans Frontières (MSF), Geneva, Switzerland.
  • Hewison C; MSF, Paris, France.
  • Mitnick C; Department of Global Health and Social Medicine, Harvard Medical School, Boston, MA, Partners In Health (PIH), Boston, MA, USA.
  • Lomtadze N; Ministry of Health, Surveillance and Strategic Planning Department, Tbilisi, Georgia.
  • Coutisson S; Médecins Sans Frontières (MSF), Geneva, Switzerland.
  • Osso E; Partners In Health (PIH), Boston, MA, USA, Harvard Medical School, Boston, MA, USA.
  • Ahmed S; Interactive Research and Development (IRD), Karachi, Pakistan.
  • Leblanc G; Zamni Lasante, Cange, Haiti.
  • Islam S; IRD, Dhaka, Bangladesh.
  • Atshemyan H; MSF, Yerevan, Armenia.
  • Nair P; MSF, Minsk, Belarus.
  • Kholikulov B; MSF, Minsk, Belarus.
  • Aiylchiev S; MSF, Osh, Kyrgyzstan.
  • Zarli K; MSF, Yangon, Myanmar.
  • Adnan S; Indus Health Network, Karachi, Pakistan.
  • Krisnanda A; IRD, Jakarta, Indonesia.
  • Padayachee S; IRD, Durban, South Africa.
  • Stambekova A; PIH, Almaty, Kazakhstan.
  • Sahabutdinova Y; PIH, Almaty, Kazakhstan.
  • Moreno P; Socios En Salud, Lima, Peru.
  • Kumsa A; PIH, Addis Ababa, Ethiopia.
  • Reshid A; PIH, Addis Ababa, Ethiopia.
  • Makaka J; PIH, Maseru, Lesotho.
  • Abebe S; PIH, Maseru, Lesotho.
  • Melikyan N; MSF, Paris, France.
  • Seung KJ; Partners In Health (PIH), Boston, MA, USA, Division of Global Health Equity, Brigham and Women´s Hospital, Boston, MA, USA.
  • Khan U; IRD, Singapore, Singapore.
  • Khan P; IRD, Singapore, Singapore.
  • Huerga H; MSF, Paris, France.
  • Rich M; Partners In Health (PIH), Boston, MA, USA, Division of Global Health Equity, Brigham and Women´s Hospital, Boston, MA, USA.
  • Varaine F; MSF, Paris, France.
Int J Tuberc Lung Dis ; 24(10): 1087-1094, 2020 10 01.
Article em En | MEDLINE | ID: mdl-33126944
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Tuberculose Resistente a Múltiplos Medicamentos / Farmacovigilância Limite: Humans Idioma: En Revista: Int J Tuberc Lung Dis Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Suíça
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Tuberculose Resistente a Múltiplos Medicamentos / Farmacovigilância Limite: Humans Idioma: En Revista: Int J Tuberc Lung Dis Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Suíça